Evidence map›Paper›PMID 30228122›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2018

Targeting intramolecular proteinase NS2B/3 cleavages for

David A Constant, Roberto Mateo, Claude M Nagamine, Karla Kirkegaard

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Viral proteases as therapeutic targets.Molecular aspects of medicine · 2022
    Review
  13. Article
  14. Article
  15. Nutritional Profile and Health Benefits ofFoods (Basel, Switzerland) · 2022
    Review
  16. PeerJ · 2022
    Article
  17. Review
  18. Article
  19. Microbiology spectrum · 2021
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

David A ConstantDepartment of Biology, Stanford University, Stanford, CA 94305.
Roberto MateoDepartment of Genetics, Stanford University School of Medicine, Stanford, CA 94305.
Claude M NagamineDepartment of Comparative Medicine, Stanford University School of Medicine, Stanford, CA 94305.
Karla KirkegaardDepartment of Genetics, Stanford University School of Medicine, Stanford, CA 94305; karlak@stanford.edu.ORCID 0000-0001-7628-3770
Stanford University · US

Funding

Supplement to Enhance Wellness and Resiliency in the Graduate EnvironmentT32GM007276 · NIGMS · STANFORD UNIVERSITY · PI MORRISON, ASHBY J. · 1985 to 2023
$32.9M
Translational Incubator CoreU19AI109662 · NIAID · STANFORD UNIVERSITY · PI GLENN, JEFFREY S · 2014 to 2019
$28.6M
NIAID NIH HHS U19 AI109662NIGMS NIH HHS T32 GM007276
6 · The paper itself

Abstract

Many positive-strand RNA viruses translate their genomes as single polyproteins that are processed by host and viral proteinases to generate all viral protein products. Among these is dengue virus, which encodes the serine proteinase NS2B/3 responsible for seven different cleavages in the polyprotein. NS2B/3 has been the subject of many directed screens to find chemical inhibitors, of which the compound ARDP0006 is among the most effective at inhibiting viral growth. We show that at least three cleavages in the dengue polyprotein are exclusively intramolecular. By definition, such a

Indexed as

ProteolysisAnimalsCell LineCricetinaeDengue VirusRNA, ViralSerine EndopeptidasesViral Nonstructural ProteinsViral ProteasesNS2B protein, flavivirusNS3 protease, dengue virusRNA, ViralSerine EndopeptidasesViral Nonstructural ProteinsViral Proteasesantiviral agentsdengue viruspolyproteinstrans-dominant inhibition

Identifiers

PMID30228122
PMCPMC6176606
OpenAlexW2892330321

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.